Skip to content
GLP-1 Decoder

Victoza Vial: What It Is, Price and How It Differs from the Pen

Victoza vial: which forms exist, which are FDA approved, and how they differ.

Active ingredient
liraglutide
Manufacturer
Novo Nordisk
How it is taken
Daily injection
FDA-approved for
Type 2 diabetes, Heart risk
Victoza vial: GLP-1 medicines as a pen, a pill and a vial

Victoza in brief

How long it remains in the body
100%50%25%0%013 h26 h39 h2.2 d2.7 d50%25%12.5%time after the dose

Its half-life is about 13 hours. After 13 h, half is gone, and once five half-lives pass (2.7 d) only about 3% is left.

Weight loss seen in its main trial
Victoza (LEAD-3)2.5 kgPlacebo1.1 kg

In LEAD-3, people with type 2 diabetes lost 2.5 kg over 52 weeks, compared with 1.1 kg on placebo.

Sources: FDA label (DailyMed).